What You Should Know About Dexamethasone for Treating COVID-19 Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: August 20, 2020 Also available in Français
Lopinavir-Ritonavir for the Treatment and Prevention of COVID-19: A Review of Clinical Effectiveness Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: August 19, 2020 Also available in Français
CADTH Emerging Health Technology for COVID-19: Favipiravir Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: August 17, 2020 Also available in Français
Dexamethasone in Patients Hospitalized for COVID-19 Product: — Science Table Drug Interventions Treatments covid19-sciencetable.ca Last Updated: August 12, 2020
Dexamethasone in the Treatment of Hospitalized Patients With COVID-19: A Critical Appraisal of the RECOVERY Study Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: July 24, 2020 Also available in Français
Gabapentin, Phenobarbital, Diazepam, and Lorazepam for the Treatment of Alcohol Withdrawal: Clinical Effectiveness and Guidelines Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: June 23, 2020 Also available in Français
Methoxyflurane for Acute Pain: Clinical Effectiveness Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: May 25, 2020 Also available in Français
Barriers Vulnerable Populations Face Regarding Adherence to COVID‑19 Public Health Measures Product: — Evidence Synthesis Network Barriers to Access Health Inequities Vulnerable Groups esnetwork.ca Last Updated: May 24, 2020